Neptune Acquires Biodroga for $15M in Cash, Stock

Loading...
Loading...
Neptune Technologies & Bioressources Inc.
NEPT
announces that it has acquired Montreal based, privately held, Biodroga Inc. for $15 million in a combination of cash and stock.  All amounts in Canadian dollars.   Biodroga is a leading solution provider of omega-3's and other functional ingredients to branded marketers in the nutraceutical industry, primarily in North America.  Their customized product offerings primarily include omega-3's, along with other essential nutritional ingredients that are used in specialty formulations.  Biodroga develops and distributes these solutions as turnkey finished supplements that are ready for sale, primarily as softgel capsules and liquids.     The business combination is highly complementary and further positions Neptune for success, by adding a new growth vehicle in a significantly larger addressable market.  "Biodroga offers a scalable solutions platform,
See full press release
Posted In: NewsM&APress Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...